Halozyme Therapeutics AGM: Shareholders Elect Directors as CEO Torley Raises 2026 Guidance
MarketBeat
Halozyme Therapeutics (NASDAQ:HALO) stockholders elected two Class I directors and approved several governance items at the company’s annual meeting, while President and CEO Helen Torley highlighted 2025 execution, recent acquisitions, new commercial agreements, and updated financial guidance.
Stoc
NASDAQ:HALO